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Milk intake and the risk of type 2 
diabetes mellitus, hypertension 
and prostate cancer
Ingestão de leite e risco de diabetes melito tipo 2,  
hipertensão e câncer de próstata
Ligia Araújo Martini1, Richard James Wood2
AbstrAct
Milk intake is widely recommended for a healthy diet. Recent evidences suggest that milk/dairy 
products are associated with a lower risk of type 2 diabetes and hypertension. On the other 
hand, high calcium intake has been associated with a higher risk of prostate cancer. The calcium 
and vitamin D content in dairy foods could have beneficial effects on glucose metabolism and 
renin/angiotensin system as well regulates body weight. The association between high dairy/
calcium consumption and prostate cancer risk are related to the presence of estrogens and 
insulin like growth factor (IGF-I) in milk. Based on the current evidence, it is possible that milk/
dairy products, when consumed in adequate amounts and mainly with reduced fat content, 
has a beneficial effect on the prevention of hypertension and diabetes. Its potential role in the 
pathogenesis of prostate cancer is not well supported and requires additional study. Arq Bras 
Endocrinol Metab. 2009;53(5):688-94.
Keywords
Milk; dairy products; calcium intake; chronic diseases
resumo
A ingestão de leite é amplamente recomendada para uma dieta saudável. Evidências recentes 
sugerem que leite e produtos lácteos estão associados a menor risco de diabetes melito tipo 
2 e hipertensão. Por outro lado, a ingestão elevada de cálcio foi associada a maior risco de 
câncer de próstata. A quantidade de cálcio e de vitamina D presentes em produtos lácteos tem 
efeito benéfico no metabolismo da glicose e no sistema renina-angiotensina, além de regular 
o peso corporal. A associação entre o consumo elevado de laticínios/cálcio e o risco de câncer 
de próstata está relacionada à presença de estrogênios e de fator de crescimento semelhante 
à insulina (IGF-I) no leite. Com base nas evidências atuais, é possível que o leite e os produtos 
lácteos, se consumidos em quantidades adequadas e, principalmente, com reduzido teor de 
gordura, tenham um efeito benéfico na prevenção da hipertensão e do diabetes. Sua função 
potencial na patogênese do câncer de próstata não é bem sustentada e requer estudos adicio-
nais. Arq Bras Endocrinol Metab. 2009;53(5):688-94.
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overview
Milk intake is widely recommended for healthy diet, not only for bone growth and maintenance, but 
also as a protein, calcium and magnesium sources as part 
of an adequate diet. Several lines of evidence suggest 
that milk and dairy products are associated with a lower 
risk of type 2 diabetes mellitus (T2DM) and hyperten-
sion. On the other hand, high calcium intake has been 
associated with a higher risk of certain types of cancer, 
mainly prostate cancer (1-6).
The present paper reviewed the evidence and poten-
tial mechanisms involved in the association of milk or 
dairy product consumption and the risk of these chronic 
diseases.
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type 2 DiAbetes mellitus 
prospective studies
The prevalence of T2DM is increasing around the 
world and it is closely connected to the rising rates of 
obesity. In addition, some epidemiologic studies have 
found an association between milk and diary product 
consumption and the risk of T2DM. For example, the 
association between dairy consumption and T2DM 
in men was investigated prospectively in the Health 
Professionals Follow-up Study (7). In 42,125 males 
followed for 12 years, the relative risk (RR) for T2DM 
for those in the top quintile of dairy intake (≥ 2.9 daily 
servings) was 0.77 (95%CI = 0.62-0.95) compared 
with those in the lowest quintile (< 0.9 daily servings) 
adjusting for total energy intake, family history of 
diabetes, smoking status, body mass index (BMI) and 
various dietary components. When the association was 
analyzed taking into account fat content, the inverse 
association was primarily limited to low fat dairy. 
However, only skim milk reached statistical significance 
(multivariate RR per serving 0.90; 95%CI = 0.83-0.97). 
In women, similar results were observed. During a ten-
year follow-up among 37,183 women, the adjusted 
RR for T2DM in the highest quintile of dairy intake 
(≥ 2.9 daily servings) was 0.79 (95%CI = 0.67-0.94) 
compared to those in the lowest quintile (< 0.9 daily 
servings). Again, the inverse association appeared to be 
mainly attributed to low-fat dairy intake (8). These two 
large epidemiological studies estimated that each daily 
serving of dairy foods was associated with an annual 
reduction in diabetes incidence of 9 and 4% in men and 
women, respectively. 
potential mechanisms
The mechanisms underlying the effects of dairy on 
T2DM development includes the calcium and vitamin 
D content in dairy foods (9) and the possible positive 
effect of high milk and calcium intake on weight control 
(10). The salutary effects of calcium and vitamin D on 
glucose homeostasis have been demonstrated in a series 
of experimental studies. The fact that pancreatic β-cells 
express vitamin D receptor (VDR), 1α-hydroxylase 
enzyme and calcium binding protein is consistent 
with an ability of this cell type to respond to the 
active in vitro form of the vitamin D [1,25(OH)2D3] 
with increased insulin secretion (11). In addition, the 
observation that mice without functioning VDR have 
lower circulating insulin concentration and higher 
plasma glucose than VDR competent wild-type mice 
is consistent with a role of vitamin D in pancreatic 
function (12). The administration of a single dose of 
1,25(OH)2D3 (calcitriol) of vitamin D to deficient rats 
increased insulin secretion and decreased blood glucose 
levels (13). The mechanism by which 1,25(OH)2D3 
might act on insulin secretion may involve calcium 
and parathyroid hormone (PTH), because a significant 
rise in cytosolic calcium levels was observed in β-cells 
after incubation with 1,25(OH)2D3, resulting in insulin 
secretion (14); continuous elevated endogenous 
plasma PTH also seemed to negatively influence insulin 
sensitivity (15). 
A cross-sectional study of Chiu and cols. (16) 
found in glucose tolerant subjects a positive association 
between serum vitamin D concentration and insulin 
sensitivity, and a negative effect of hypovitaminosis D 
on β-cell function. However, in a large clinical trial, 
no benefit was observed on glucose homeostasis from 
the daily administration of 1,000 mg of calcium and 
400 IU of vitamin D for seven years (17). A systematic 
review and a meta-analysis (9), that combined data 
from studies evaluating the association of serum 25-
OHD levels and dietary calcium with prevalent and/
or incident DM, suggests that both nutrients may 
have a role in the prevention of T2DM – but only in 
populations at high risk of T2DM, such as those with 
glucose intolerance (impaired glucose tolerance or 
impaired fasting glycemia).
Some studies have shown that calcium and dairy 
product intake may have an anti-obesity effect (10,18), 
which would be desirable for the prevention of T2DM. 
There is evidence that synthesis of the hormonally ac-
tive 1,25(OH)2D3 metabolite can be suppressed by high 
dietary calcium intake. Based on experimental observa-
tions in the agouti mouse obesity model and cultured 
human adipocytes, Zemel and Sun (18) proposed a 
potential mechanism whereby dietary calcium, which 
would affect plasma 1,25(OH)2D3 concentration, in-
fluences the development of obesity. They proposed 
that, during a low calcium diet, plasma 1,25(OH)2D3 
and PTH increase and exert coordinated effects on hu-
man adipocyte lipogenic and lipolytic systems, resulting 
in increased lipid storage, whereas the suppression of 
these hormones, during consumption of high calcium 
diets, inhibits lipid storage. Calcitriol via the VDR has 
also been shown in cell culture studies to suppress the 
expression of uncoupling protein 2 (UCP2), which 
would decrease thermogenesis and energy expenditure. 
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In addition, 1,25(OH)2D3 exerts a dose-dependent ef-
fect on adipocyte apoptosis and regulates adipose tissue 
fat depot location and expansion by promoting gluco-
corticoid production and release via up-regulation of 
the 11β-hydroxysteroid dehydrogenase (11β-HSD), 
which generates active cortisol from inactive cortisone 
(10,18). However, a randomized double-blind clinical 
trial with cholecalciferol supplementation during one 
year (19) did not support the hypotheses that vitamin D 
could contribute to weight loss.
It has also been suggested that other components in 
dairy products, such as lactose and dairy protein, may 
enhance satiety and reduce the risk of overweight and 
obesity (risk factors for T2DM) relative to other high-
carbohydrate foods and beverages (20). However, a 
recent evaluation of clinical trials that assessed the effect 
of dairy product or calcium intake on adiposity, with or 
without concomitant energy restriction (21), did not 
support this hypothesis.
Thus, while there is support from prospective cohort 
studies that high dairy intake is associated with lower 
risk of T2DM, there is as yet no convincing evidence 
from clinical trials that increased dairy or milk intake 
would help to reduce the incidence of this disease. 
Possible biological mechanisms underlying any inverse 
association of milk/dairy consumption and glucose 
metabolism are unclear.
Hypertension
Low fat dairy foods are one of the main components of 
the Dietary Approaches to Stop Hypertension (DASH) 
diet, which has been presented with the aim of reducing 
blood pressure (22). In the DASH Study, patients 
(n = 459) were randomly assigned to receive, during 
eight weeks, a control diet (low in fruits, vegetables and 
dairy products); a diet rich in fruits and vegetables; or a 
“combination” diet rich in fruits, vegetables, and low-
fat dairy products and with reduced saturated and total 
fat. Sodium intake and body weight were maintained 
at constant levels. At baseline, the mean systolic and 
diastolic blood pressures were 131.3 ± 10.8 mmHg 
and 84.7 ± 4.7 mmHg, respectively. The combination 
diet, that included low fat dairy products, significantly 
reduced systolic and diastolic blood pressure by 5.5 and 
3.0 mmHg more, respectively, compared to the control 
diet, while the fruits-and-vegetables-diet reduced, alone, 
systolic blood pressure by 2.8 mmHg (p < 0.001) and 
diastolic blood pressure by 1.1 mmHg (p = 0.07) more 
than the control diet. Similar patterns of response were 
also observed among 133 subjects with hypertension, 
the combination diet significantly reduced systolic and 
diastolic blood pressure by 11.4 and 5.5 mmHg more, 
respectively, than the control diet.
Dietary intake of dairy products, calcium and 
vitamin D and the risk of incident hypertension in 
middle-aged and older women have been investigated 
by Wang and cols. (23) in the Women’s Health Initiative 
Study. Incident cases of hypertension (n = 8,710) were 
identified from annual questionnaires, during a ten-
year follow-up. After adjusting for major hypertension 
risk factors, the RR of incident hypertension across 
increasing quintiles of low-fat dairy product intake 
were 1.00 (23), 0.98, 0.97, 0.95, and 0.89 (p for 
trend = 0.001). Furthermore, the risk of hypertension 
decreased in the higher quintiles of dietary calcium 
and vitamin D (multivariate RR in the highest calcium 
quintile: 0.87, and vitamin D quintile: 0.95). 
Recently, an inverse association between dairy intake 
and hypertension was observed in the Rotterdam Study 
(24). The incidence of hypertension was examined in 
2,245 individuals for two and six years. The hazard 
ratio for hypertension was 0.76 (95%CI = 0.61-0.96) in 
the highest quartile of energy-adjusted dairy products 
intake (median intake = 691 g/d) compared to the 
lowest (median intake = 164 g/d) quartile (p for trend 
= 0.008). For low-fat dairy, the hazard ratio was 0.69 
(95%CI = 0.56-0.86) in the highest quartile (p for 
trend = 0.003). After six years, the hazard ratio was 
0.84 (95%CI = 0.70-1.01; p for trend = 0.09) and 0.84 
(95%CI = 0.70-1.01; p for trend = 0.07) total dairy and 
low-fat dairy, respectively.
Interestingly, The Coronary Artery Risk Develop-
ment in Young Adults (CARDIA) Study also reported a 
lower ten-year cumulative incidence of hypertension in 
young adult overweight subjects with dairy consump-
tion in the highest quartile (≥ 35 servings/week) (20).
proposed mechanism
The proposed mechanism, by which dairy products 
reduce blood pressure, remains uncertain, but again, 
calcium and vitamin D content in dairy products, as well 
as milk peptides, are hypothesized to exert a beneficial 
effect on blood pressure by inhibiting the angiotensin 
I converting enzyme (ACE), modulating endothelium 
function or affecting body weight (25-27).
Zemel (28) proposed a mechanism by which the 
regulation of intracellular calcium plays a key role in 
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hypertension and obesity. According to his model, 
dysregulation of calcium homeostasis induced by 
a low dairy/calcium diet would increase plasma 
1,25(OH)2D3 concentration, which would increase 
vascular smooth muscle intracellular calcium, thereby 
increasing peripheral vascular resistance and blood 
pressure. Calcium influx in human adipocytes is also 
stimulated by 1,25(OH)2D3, resulting in stimulation 
of lipogenesis, inhibition of lipolysis and expansion of 
triglyceride stores. Accordingly, suppression of plasma 
1,25(OH)2D3 by high dietary calcium may contribute 
to the prevention and management of obesity and 
hypertension.
Hatton and McCarron (29) have reviewed possible 
mechanisms by which low dietary calcium might affect 
blood pressure. One possible mechanism is related to 
an increase in urinary calcium excretion due to a de-
fect in calcium reabsorption. As a consequence, there is 
an increase in PTH secretion, in an attempt to restore 
plasma calcium. The elevated plasma PTH concentra-
tion is responsible for an increase blood pressure via 
activation of renin-angiotensin system (30). Other po-
tential mechanisms were also discussed, including direct 
effects on vascular smooth muscle, calcium-regulating 
and calcium-sensitive hormones, interactions between 
calcium and sodium-potassium, and increased appetite 
for sodium, when calcium intake is low. 
The relationship between vitamin D and blood 
pressure control was demonstrated in experimental 
studies, which presented that the 1,25(OH)2D3 
administration could inhibit renin expression at the 
juxtaglomerular apparatus (31) and also block vascular 
smooth muscle cells proliferation (32). In fact, several 
human studies demonstrated an inverse association 
between serum 1,25(OH)2D3 concentration and blood 
pressure, as well as with renin activity (33-36). 
Another potential mechanism is related to milk-
derived peptides that can reduce blood pressure by 
inhibition of ACE. Anti-hypertensive peptides that 
inhibit ACE have been isolated from milk products 
(27) and it has been suggested that peptides with 
hydrophobic amino acids at the C-terminal position 
would be the most likely ACE inhibitors (37).
Thus, there is consistent evidence from some large 
prospective studies that high diary intake is associated 
with a lower risk of incident hypertension. The biological 
mechanisms are still unclear, but may involve calcium-
mediated effects on circulating calcemic hormones, 
such as PTH and 1,25(OH)2D3, that influence vascular 
resistance, or milk-derived peptides, that influence 
mediators of blood pressure control. 
prostAte cAncer
The relationship between calcium and dairy food 
intake in fatal prostate cancer was evaluated in the 
Health Professionals Follow-up Study (38), in which 
47,750 healthy males over 16 years were followed. The 
investigators identified 3,544 cases of prostate cancer, 
being 523 advanced and 312 fatal. Higher calcium intake 
was not associated with total or non-advanced cases of 
prostate cancer. However, they observed a significantly 
higher risk of advanced or fatal cases in prostate cancer 
patients with reported calcium intakes of 1,500 to 
1,999 mg/d, with RR of 1.87 (95%CI = 1.17-2.01), 
while those with calcium intakes ≥ 2,000 mg/d had a 
RR of 2.43 (95%CI = 1.32-4.48; p for trend = 0.003). 
However, when total dairy products and calcium intake 
were modeled simultaneously, no significant increase in 
RR was observed for total or advanced prostate cancer: 
RR of 1.05 (95%CI = 0.91-1.21) for the highest 
dairy intake quintile (3.72 servings/day) compared 
to the lowest dairy intake quintile (0.5 servings a day) 
for total prostate cancer; and RR of 1.08 (95%CI = 
0.75-1.55) for the highest dairy intake compared to 
the lowest dairy intake for advanced prostate cancer. 
The researchers concluded that high calcium intakes 
(≥ 1.500 mg/d) were associated with an increased risk 
of poorly differentiated, clinically advanced and fatal 
prostate cancer, but not with generally moderate to 
well-differentiated cancer. Additionally, no association 
was observed with dairy foods.
In the Multiethnic Cohort Study (39), 82,483 men 
were followed for up to eight years. During this time, 
4,004 cases of prostate cancer were identified. In com-
parison with the findings of the Health Professionals 
Follow-up Study (38), no association was observed be-
tween calcium (or vitamin D intake) with prostate can-
cer risk, even in those with calcium intakes ≥ 1,300 mg/d. 
Also, no association was observed between dairy pro-
ducts and total milk consumption and prostate cancer 
risk. However, the Multiethnic Cohort Study find that 
low/nonfat milk consumption was related to an in-
creased risk (RR = 1.16; 95%CI = 1.04-1.29) of prostate 
cancer for the highest (≥ 243 g/day) compared to the 
lowest (0 servings/day; p for trend = 0.02). On the oth-
er hand, a marginally reduced risk of incident prostate 
cancer was observed for whole milk consumption (RR = 
Milk intake and chronic diseases
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0.88; 95%CI = 0.77-1.00) for the highest (≥ 163 g/day) 
compared to the lowest (0 servings/day; p for trend = 
0.03). These findings on low/nonfat and whole milk 
were related to localized or low-grade prostate cancer, 
but not to high advanced or high grade prostate cancer.
Additionally, a meta-analysis of 26,769 cases of pros-
tate cancer accrued from 45 observational studies did 
not support an association between dairy product con-
sumption and an increased risk of prostate cancer (40).
possible mechanisms
The hypothesized mechanisms concerning the associa-
tion between dairy product/calcium consumption and 
prostate cancer risk are focused on the presence of es-
trogens and insulin like growth factor (IGF-I) in milk 
and also that a high calcium consumption lowers the 
level of circulating 1,25(OH)2D3, an inhibitor of pros-
tate carcinogenesis (3,41). 
The effects of estrogens on prostate cancer cells 
are mediated by specific estrogen receptors (ER). It 
has been demonstrated that ER-β activation limits cell 
proliferation directly or through ER-α inhibition, and 
loss of ER-β has been associated with tumor progression 
(42). Regarding the presence of estrogens in milk, it was 
been demonstrated that such content is very low (43); 
the mean 17β-estradiol concentration in samples of 
whole cow milk was only 1.4 ± 0.2 pg/mL. Therefore, 
one cup of whole milk would provide only 330 pg – a 
very small amount compared to a typical mean estradiol 
concentration in older men, of 21 pg/mL. Thus, 
although serum estrogen concentration is positively 
related to prostate cancer (42), the effect of even five 
cups of milk/day, which would supply about 1.300 
mg calcium/day, would have a minimal impact on 
plasma estrogen concentration. Another important 
consideration is that 17β-estradiol is fat-soluble and its 
concentration is skim milk may be very low (3). Thus, 
the role of estrogen content in milk and its association 
with prostate cancer need further investigations.
Besides the idea of negative effects of IGF-I content 
in milk on prostate cancer, a recent review suggest that 
IGF-I from milk is a promoter of chronic Western diseases 
(2). IGF-1 is a peptide hormone expressed in most 
tissues, which shares significant structural and functional 
similarities with insulin. There is accumulating evidence 
of a role for IGF-1 in multiple vascular pathologies, 
including atherosclerosis, hypertension, angiogenesis, 
and diabetic vascular disease (44). Giovannucci and 
cols. (6) observed, in healthy middle-aged men, that 
the consumption of animal protein, including milk, fish 
and poultry, but not red meat, was associated with an 
increase in serum IGF-I concentration. In a previous 
study, the same group of investigators observed a 
modest increase in circulating IGF-I in men with higher 
dairy consumption, although intake of low-fat milk in 
that study was associated with lower risk of colorectal 
cancer (5). Cows treated with recombinant growth 
hormone had increased levels of IGF-I in their milk, 
even after milk pasteurization and homogenization 
(45). However, oral IGF-I is not absorbed in humans 
(46). Considering such observations, the potential 
role of milk/dairy in the pathogenesis of cancer and 
its association with milk IGF-I content is not well 
supported and requires additional study.
Additional complications in evaluating the potential 
health benefits or risks of high dairy/calcium consump-
tion are that opposite effects may exist for cancers of 
different origins, such as colon cancer. 
milK AnD cAlcium consumption
The estimation of adequate and optimal milk/dairy 
intake by populations is not settled. One measure of 
evaluation that can be used is to estimate if intake of 
these foods is in adequate quantities by evaluating the 
nutritional needs of a major component of milk/dairy 
products/calcium. It is well established that calcium 
intake is below recommended nutritional levels in almost 
all countries. Table 1 represents mean calcium intake 
in several countries. The studies used different dietary 
methods to evaluate calcium intakes, as well different 
sample sizes and age groups. In general, however, mean 
calcium intake is higher during adolescence and lower in 
the elderly (47). Moreover, there is considerable inter-
group variability and a five-fold spread in mean calcium 
intake between some groups. The lowest reported 
calcium intake calculated was 255 mg/day (men older 
than 40 years, in Brazil) (48) and the highest reported 
calcium intake was 1,395 mg/day (men, 18 to 24 years, 
in German). Considering that one serving size of milk/
dairy products contains approximately 250 to 300 mg/
calcium, roughly the mean milk/dairy products intake 
is ≅ 3 servings/day. In the epidemiological studies 
above, a higher risk of prostate cancer was observed 
when calcium intake was greater than 1,500 mg/day 
and dairy intake was ≥ 3.72 servings/day (38). Such 
observations demonstrated that, in most countries, the 
mean intake of calcium and milk/dairy products is below 
Milk intake and chronic diseases
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table 1. Mean calcium intake around the world
Country
Survey name and/or areas covered Calcium intake (mg/day)
Both sexes
min - max
Male
min - max
Female
min - max
Australia National Nutrition Survey 866-1,054 691-794
Austria Vienna and lower Austria 796-1,095
Brazil* Brazos Study 255-545 276-591
Britain National Diet and Nutrition Survey 625-1,035 595-903
Denmark Danskerns Kostvaner 822-1,362 864-1,100
Finland National FINNDIET 1,075-1,391 946-1,001
France L’énquête INCA 790-884
Germany German Nutrition Survey 949-1,395 973-1,129
Ireland North/South Ireland Food Consumption Survey 840-996 722-742
Italy Nationwide Nutritional Survey of Food Behaviour 797-893 826-936 742-850
The Netherlands Dutch National Food Consumption Survey 846-1,095 790-995
New Zealand National Nutrition Survey 799-998 670-783
Singapure National Nutrition Survey 480-506 445-523 446-503
Sweden Riksmaten 1,035-1,201 901-973
United States NHANES 721-938 797-1,081 660-860
Adapted from Looker (47). 
*Data of Brazil from Pinheiro and cols. (48).
the cut-offs related to altered risk of prostate cancer. 
Furthermore, it has been demonstrated that milk intake 
decreases as carbonated beverages intake increases. An 
evaluation of the trends in milk and carbonated soft 
drinks consumption, from 1945 to 2001, by the US 
Department of Agriculture/Economic Research Center, 
clearly demonstrated that Americans drank nearly 2.5 
more soda than milk (49). However, soda consumption 
has also been related to chronic diseases risk (50-52).
conclusions 
Based on the current evidence, it is possible that milk/
dairy products, when consumed in adequate amounts 
and, mainly, with reduced fat content, have a beneficial 
effect on the prevention of important chronic diseases, 
as hypertension and diabetes. The role of milk/dairy 
products, as well as calcium intake, in the development 
of prostate cancer, is relatively unclear at this point. 
However, it may be prudent for men to avoid very 
high intakes of milk/dairy products, which would not 
be a problem for most individuals. Considering that 
milk is an important source of several nutrients, such 
as protein, calcium, magnesium and potassium, health 
professionals and researchers can safely advise that the 
consumption of adequate amounts of low-fat milk/
dairy products should be part of a healthy diet.
Disclosure: no potential conflict of interest relevant to this article 
was reported. 
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